4//SEC Filing
Walsh Jeffrey T. 4
Accession 0001209191-19-024478
CIK 0001293971other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:17 PM ET
Size
11.1 KB
Accession
0001209191-19-024478
Insider Transaction Report
Form 4
Walsh Jeffrey T.
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-04-10−1,500→ 13,021 totalExercise: $24.47Exp: 2024-03-03→ Common Stock (1,500 underlying) - Sale
Common Stock
2019-04-10$156.44/sh−1,100$172,085→ 41,321 total - Exercise/Conversion
Common Stock
2019-04-10$24.47/sh+1,500$36,705→ 42,421 total - Sale
Common Stock
2019-04-10$157.23/sh−400$62,891→ 40,921 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- [F2]The range of prices for the transaction reported on this line was $156.09 to $156.62. The average weighted price was $156.4409. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The range of prices for the transaction reported on this line was $157.09 to $157.38. The average weighted price was $157.2275. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Documents
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeother
Related Parties
1- filerCIK 0001578251
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:17 PM ET
- Size
- 11.1 KB